The global laboratory proficiency testing market is witnessing steady growth as laboratories increasingly prioritize testing accuracy, quality assurance, and regulatory compliance. Laboratory proficiency testing (PT) is an external quality assessment process used to evaluate the performance of laboratories by comparing their testing results against established standards or results obtained from other participating laboratories. These programs help identify analytical errors, improve testing procedures, and ensure the reliability of laboratory-generated results.
According to Kings Research, the global laboratory proficiency testing market was valued at USD 1,520.50 million in 2024 and is projected to grow from USD 1,609.49 million in 2025 to USD 2,525.39 million by 2032, registering a compound annual growth rate (CAGR) of 6.65% during the forecast period.
The increasing prevalence of chronic and infectious diseases, expansion of diagnostic testing services, and growing importance of laboratory accreditation are supporting market expansion. Healthcare institutions, pharmaceutical companies, biotechnology organizations, and research laboratories increasingly depend on proficiency testing programs to maintain consistent testing standards.
Furthermore, advancements in molecular diagnostics, automation, artificial intelligence, and laboratory information management systems are improving the efficiency of proficiency testing programs. These developments are creating new opportunities for providers offering comprehensive external quality assessment solutions.
Increasing Regulatory and Accreditation Requirements Supporting Market Growth
Stringent regulatory requirements and laboratory accreditation standards are among the primary factors driving the laboratory proficiency testing market. Laboratories must demonstrate their technical competence and maintain consistent testing performance to receive and retain accreditation.
International standards such as ISO 15189 and ISO/IEC 17025 emphasize laboratory quality management, technical competence, and reliable testing procedures. Similarly, regulatory frameworks such as the Clinical Laboratory Improvement Amendments (CLIA) in the United States establish requirements for proficiency testing in clinical laboratories.
Participation in proficiency testing programs allows laboratories to evaluate their analytical performance using externally supplied samples. The results help identify systematic errors, equipment-related problems, and inconsistencies in testing procedures.
In addition, pharmaceutical and biotechnology companies depend on reliable laboratory testing during drug development, clinical research, and manufacturing quality control. Proficiency testing supports the validation of laboratory procedures and strengthens confidence in analytical results.
As regulatory authorities continue to emphasize quality management and testing reliability, demand for external quality assessment services is expected to increase.
Rising Demand for Accurate Clinical Diagnostics
The increasing demand for accurate clinical diagnostics is contributing significantly to market development. Hospitals, diagnostic centers, and specialized laboratories perform a growing number of tests for infectious diseases, cancer, cardiovascular conditions, and metabolic disorders.
Diagnostic accuracy is essential for appropriate disease identification and treatment decisions. Even minor variations in laboratory testing procedures can affect clinical results and potentially influence patient management.
Proficiency testing programs help laboratories evaluate their analytical capabilities by comparing their results with established reference values and peer laboratory performance.
The growing adoption of molecular diagnostics, genetic testing, and personalized medicine is further increasing the importance of external quality assessment. These advanced diagnostic techniques require specialized instruments, trained professionals, and standardized testing procedures.
Additionally, increasing demand for infectious disease surveillance and early disease detection is encouraging laboratories to participate in specialized proficiency testing programs. This trend is expected to create sustained demand across healthcare and research applications.
Technological Advancements Transforming Proficiency Testing Programs
Technological innovation is transforming the way proficiency testing programs are developed, managed, and evaluated. Providers are increasingly integrating laboratory automation, artificial intelligence, cloud computing, and advanced data analytics into their quality assessment platforms.
Automation helps streamline sample preparation, distribution, testing workflows, and result collection. By reducing manual intervention, automated systems can minimize operational errors and improve the consistency of testing procedures.
Artificial intelligence and machine learning technologies are creating additional opportunities by supporting the analysis of laboratory performance data. These systems can identify unusual result patterns, recognize performance deviations, and assist providers in evaluating participating laboratories.
Cloud-based platforms are also improving communication between proficiency testing providers and participating laboratories. Laboratories can submit results electronically, access performance reports, and monitor quality indicators through centralized digital systems.
Furthermore, big data analytics allows providers to compare performance across large laboratory networks. This supports more comprehensive benchmarking and helps identify areas requiring corrective action.
The increasing adoption of digital quality management solutions is expected to improve operational efficiency and strengthen the role of technology in proficiency testing.
Growing Adoption of Polymerase Chain Reaction Testing
Polymerase chain reaction (PCR) represents a major technology segment in the laboratory proficiency testing market. The segment generated USD 343.94 million in revenue in 2024, reflecting its widespread application in molecular diagnostics and infectious disease testing.
PCR technology enables laboratories to detect specific genetic material in biological samples. It is widely used for identifying infectious pathogens, detecting genetic abnormalities, and supporting cancer-related molecular testing.
The increasing use of PCR-based diagnostics has created a need for specialized proficiency testing programs that evaluate the accuracy and reliability of molecular testing procedures.
External quality assessment providers offer standardized samples that allow laboratories to assess their ability to detect specific genetic targets and identify potential variations in analytical performance.
The growing adoption of advanced molecular testing technologies is expected to support continued demand for PCR-based proficiency testing.
The PCR segment is projected to reach USD 639.39 million by 2032, supported by increasing diagnostic requirements and the expansion of molecular laboratory capabilities.
Increasing Demand Across Clinical Diagnostics and Pharmaceutical Industries
Clinical diagnostics represents an important industry segment within the laboratory proficiency testing market. The segment accounted for 36.25% of the market share in 2024 and is expected to reach USD 891.27 million by 2032.
Clinical diagnostic laboratories conduct tests that support disease identification, treatment monitoring, and preventive healthcare. These facilities require reliable analytical processes to ensure that reported results meet established quality standards.
Proficiency testing programs help clinical laboratories evaluate the performance of diagnostic instruments, reagents, and testing methodologies. Regular participation also supports accreditation requirements and continuous quality improvement.
The pharmaceutical industry represents another important application area. Pharmaceutical companies conduct extensive laboratory testing during drug discovery, development, manufacturing, and quality control.
Similarly, biotechnology organizations depend on proficiency testing to maintain the reliability of specialized analytical methods used in biologics development and molecular research.
Microbiology laboratories also require external quality assessment programs to evaluate pathogen identification, antimicrobial susceptibility testing, and other microbiological procedures.
Increasing research investments and the expansion of specialized testing applications are expected to strengthen demand across these industries.
Growing Importance of Academic and Research Laboratories
Academic and research laboratories play an important role in the laboratory proficiency testing market because of their involvement in scientific research, experimental testing, and advanced analytical studies.
These institutions conduct complex laboratory procedures involving molecular biology, microbiology, chemistry, genetics, and pharmaceutical research. Maintaining consistent testing standards is essential for producing reliable research findings.
The academic and research laboratories segment accounted for the largest end-user revenue share of 34.71% in 2024. It is projected to reach USD 846.43 million by 2032.
Proficiency testing enables research institutions to assess their technical capabilities and compare laboratory performance against recognized standards.
Furthermore, increasing collaboration between universities, biotechnology companies, and pharmaceutical research organizations is creating demand for reliable external quality assessment programs.
The expansion of specialized research facilities and investments in advanced laboratory infrastructure are expected to support the segment throughout the forecast period.
Market Segmentation Analysis
The laboratory proficiency testing market is segmented based on technology, industry, end user, and region.
By technology, the market includes cell culture, polymerase chain reaction (PCR), immunoassays, chromatography, spectrometry, and others. PCR represents a major segment because of its widespread use in molecular diagnostics and infectious disease detection. Immunoassays support the evaluation of laboratory performance in hormone testing, infectious disease screening, and other diagnostic applications.
Based on industry, the market is categorized into clinical diagnostics, pharmaceuticals, biologics, and microbiology. Clinical diagnostics dominates the industry segmentation because of the high volume of medical laboratory tests and the importance of accurate patient results.
By end user, the market includes hospitals and clinics, academic and research laboratories, contract research organizations (CROs), and public health laboratories. Academic and research laboratories represent the largest end-user segment, supported by increasing research activities and demand for standardized analytical procedures.
Geographically, the market covers North America, Europe, Asia Pacific, the Middle East and Africa, and South America.
Regional Outlook of the Laboratory Proficiency Testing Market
North America
North America dominated the global laboratory proficiency testing market with a share of 32.19% in 2024, representing a valuation of USD 489.45 million.
The region benefits from established healthcare infrastructure, stringent regulatory frameworks, and the presence of leading pharmaceutical and biotechnology companies.
The United States represents a major contributor because of its well-developed diagnostic laboratory network and regulatory requirements under CLIA.
Increasing investments in precision medicine, molecular diagnostics, and clinical research are encouraging laboratories to participate in external quality assessment programs.
Additionally, the presence of established proficiency testing providers and research institutions is supporting regional market development.
Asia Pacific
Asia Pacific is expected to register the fastest growth, with a projected CAGR of 8.18% during the forecast period.
Increasing healthcare expenditure, expanding diagnostic laboratory networks, and growing awareness of laboratory accreditation are supporting regional market expansion.
China, India, Japan, South Korea, and Australia represent important markets for proficiency testing services.
In India, increasing adoption of NABL accreditation and the implementation of internationally recognized laboratory standards are encouraging diagnostic facilities to strengthen quality management practices.
The expansion of pharmaceutical manufacturing, biotechnology research, and public health laboratories is also creating opportunities for proficiency testing providers.
Europe
Europe represents an important market due to its established laboratory infrastructure and strong emphasis on quality assurance and regulatory compliance.
Countries such as Germany, the United Kingdom, France, and Italy are contributing to regional demand.
The adoption of ISO 15189 standards, growing molecular diagnostic activities, and increasing pharmaceutical research investments are supporting the expansion of proficiency testing programs.
Middle East and Africa
The Middle East and Africa market is benefiting from investments in healthcare infrastructure, diagnostic laboratory modernization, and quality accreditation initiatives.
Countries such as Saudi Arabia and the United Arab Emirates are expanding laboratory capabilities to improve healthcare services and testing reliability.
South America
South America is experiencing increasing demand for laboratory quality assessment services as diagnostic networks and pharmaceutical manufacturing capabilities expand.
Brazil and Argentina represent important markets, supported by investments in healthcare infrastructure, public health programs, and laboratory accreditation.
Key Challenges Facing the Market
Despite promising growth opportunities, the laboratory proficiency testing market faces several challenges that may affect its expansion.
High operational and capital costs represent a major barrier, particularly for smaller laboratories with limited financial resources. Advanced analytical instruments, specialized reagents, sample preparation, and skilled personnel increase the overall cost of participating in proficiency testing programs.
Sample transportation and storage also create operational challenges. Proficiency testing materials must maintain appropriate conditions during distribution to ensure accurate and consistent evaluation.
Additionally, laboratories operating in remote regions may experience difficulties accessing specialized testing programs and maintaining regular participation.
The growing complexity of molecular diagnostics and advanced analytical procedures also requires specialized proficiency testing materials and qualified technical personnel.
Providers are addressing these challenges through digital reporting platforms, scalable testing programs, improved logistics, and technology-driven assessment solutions.
Competitive Landscape and Key Market Players
The laboratory proficiency testing market is characterized by competition among established external quality assessment providers, professional organizations, and specialized laboratory service companies.
Market participants are focusing on expanding their testing portfolios, improving digital reporting capabilities, and developing specialized assessment programs to address emerging diagnostic requirements.
Major companies operating in the market include:
- The College of American Pathologists
- API
- Randox Laboratories Ltd.
- UK NEQAS Microbiology
- EMQN
- Weqas
- SKML
- GenQA
- LGC Clinical Diagnostics (SeraCare)
- Association of American Feed Control Officials
- AOAC INTERNATIONAL
- CTS, Inc.
- INSTAND
- Reference Institute for Bioanalytics
- IQMH
These organizations are strengthening their market positions through technological improvements, specialized testing programs, strategic collaborations, and geographical expansion.
The introduction of new proficiency testing schemes for emerging infectious diseases and specialized molecular diagnostics is also creating opportunities for market participants.
Future Opportunities in the Laboratory Proficiency Testing Market
The future of the laboratory proficiency testing market will be shaped by advancements in molecular diagnostics, laboratory automation, artificial intelligence, and digital quality management.
One major opportunity lies in the growing demand for specialized proficiency testing programs for genetic testing, oncology diagnostics, and personalized medicine. As laboratories adopt more advanced diagnostic methods, the need for reliable external validation is expected to increase.
Artificial intelligence and cloud-based analytics are also expected to transform proficiency testing operations. These technologies can improve performance monitoring, simplify result interpretation, and support faster identification of analytical deviations.
Emerging economies present additional growth opportunities because of expanding diagnostic infrastructure and increasing adoption of international accreditation standards.
Furthermore, growing investments in pharmaceutical research, biologics manufacturing, and infectious disease surveillance are expected to create demand for specialized external quality assessment services.
Providers that develop cost-effective, technology-enabled, and customized testing solutions are likely to benefit from these opportunities.
Conclusion
The global laboratory proficiency testing market is positioned for steady expansion as healthcare institutions, pharmaceutical companies, and research organizations increasingly prioritize laboratory accuracy and quality assurance.
Growing regulatory requirements, increasing adoption of molecular diagnostics, and advancements in automation and data analytics are creating significant opportunities for market participants.
Although high operational costs, sample distribution challenges, and technical complexity remain important barriers, continuous innovation is expected to improve the accessibility and efficiency of proficiency testing services.
With the market projected to reach USD 2,525.39 million by 2032, proficiency testing will remain an essential component of laboratory quality management. Increasing investments in digital platforms, specialized testing programs, and international accreditation are expected to strengthen the industry’s role in ensuring reliable laboratory results worldwide.